{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:54:58Z","timestamp":1787162098544,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002543","name":"Pusan National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics & Neonatology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.pedneo.2021.01.005","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T11:23:37Z","timestamp":1611401017000},"page":"271-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Non-carbapenem antimicrobial therapy in young infant with urinary tract infections caused by community-acquired extended-spectrum \u03b2-lactamase-producing Escherichia coli"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-3672","authenticated-orcid":false,"given":"Kyo Jin","family":"Jo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukdong","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yeon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5860-821X","authenticated-orcid":false,"given":"Su Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2021.01.005_bib1","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1542\/peds.2005-1673","article-title":"Incidence and predictors of serious bacterial infections among 57- to 180-day-old infants","volume":"117","author":"Hsiao","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2021.01.005_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1542\/peds.2009-1070","article-title":"Performance of low-risk criteria in the evaluation of young infants with fever: review of the literature","volume":"125","author":"Huppler","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2021.01.005_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/CMR.18.2.417-422.2005","article-title":"Diagnosis and management of pediatric urinary tract infections","volume":"18","author":"Zorc","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.pedneo.2021.01.005_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s15010-011-0132-6","article-title":"Extended-spectrum \u03b2-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy","volume":"39","author":"Meier","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.pedneo.2021.01.005_bib5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1742-1241.2012.02991.x","article-title":"Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria","volume":"66","author":"Briongos-Figuero","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.pedneo.2021.01.005_bib6","doi-asserted-by":"crossref","first-page":"e12448","DOI":"10.1371\/journal.pone.0012448","article-title":"Changing epidemiology of serious bacterial infections in febrile infants without localizing signs","volume":"5","author":"Watt","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.pedneo.2021.01.005_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11255-010-9768-x","article-title":"Antimicrobial susceptibility of pediatric uropathogens in Thrace, Greece","volume":"43","author":"Mantadakis","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.pedneo.2021.01.005_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijantimicag.2011.09.006","article-title":"Antimicrobial therapy of urinary tract infections in children","volume":"38","author":"Beetz","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pedneo.2021.01.005_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jped.2016.06.009","article-title":"Urinary tract infection caused by community-acquired extended-spectrum \u03b2-lactamase-producing bacteria in infants","volume":"93","author":"Kim","year":"2017","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.pedneo.2021.01.005_bib10","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s10157-019-01775-w","article-title":"Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole","volume":"23","author":"Horie","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.pedneo.2021.01.005_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003495-200363040-00002","article-title":"Extended spectrum \u03b2-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment","volume":"63","author":"Rupp","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.pedneo.2021.01.005_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.pedneo.2021.01.005_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3947\/ic.2013.45.4.415","article-title":"Outcome of antimicrobial therapy of pediatric urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae","volume":"45","author":"Lee","year":"2013","journal-title":"Infect Chemother"},{"key":"10.1016\/j.pedneo.2021.01.005_bib14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jiac.2017.04.006","article-title":"Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli","volume":"23","author":"Abe","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.pedneo.2021.01.005_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12879-015-1153-z","article-title":"Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum \u03b2-lactamase-producing Escherichia coli or Klebsiella pneumoniae","volume":"15","author":"Han","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.pedneo.2021.01.005_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.14776\/piv.2015.22.1.29","article-title":"Febrile urinary tract infections caused by community-acquired extended-spectrum \u03b2-lactamase-producing and-nonproducing bacteria: a comparative study","volume":"22","author":"Ahn","year":"2015","journal-title":"Pediatr Infect Vaccine"},{"key":"10.1016\/j.pedneo.2021.01.005_bib17","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.ijid.2012.09.010","article-title":"The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae","volume":"17","author":"Doi","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.pedneo.2021.01.005_bib18","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1093\/jac\/dku215","article-title":"The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"69","author":"Park","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pedneo.2021.01.005_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1542\/peds.2011-1330","article-title":"Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months","volume":"128","author":"Roberts","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2021.01.005_bib20","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.3346\/jkms.2019.34.e228","article-title":"Change in the annual antibiotic susceptibility of Escherichia coli in community-onset urinary tract infection between 2008 and 2017 in a tertiary care hospital in Korea","volume":"34","author":"Kim","year":"2019","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.pedneo.2021.01.005_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3339\/jkspn.2019.23.1.22","article-title":"Antibiotic sensitivity patterns in children with urinary tract infection: retrospective study over 8 years in a single center","volume":"23","author":"Woo","year":"2019","journal-title":"Child Kidney Dis"},{"key":"10.1016\/j.pedneo.2021.01.005_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jpeds.2010.06.053","article-title":"Febrile urinary tract infections in 0- to 3-month-old infants: a prospective follow-up study","volume":"158","author":"Ismaili","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.pedneo.2021.01.005_bib23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mib.2006.08.011","article-title":"The CTX-M beta-lactamase pandemic","volume":"9","author":"Cant\u00f3n","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.pedneo.2021.01.005_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1139\/w03-111","article-title":"Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases","volume":"50","author":"Walther-Rasmussen","year":"2004","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.pedneo.2021.01.005_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jac\/dki166","article-title":"Emergence of Enterobacteriaceae producing extended-spectrum \u03b2-lactamases (ESBLs) in the community","volume":"56","author":"Pitout","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pedneo.2021.01.005_bib26","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum \u03b2-lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pedneo.2021.01.005_bib27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijantimicag.2018.07.021","article-title":"Beta-lactam\/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis","volume":"52","author":"Sfeir","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pedneo.2021.01.005_bib28","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jac\/dkl102","article-title":"Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin\/clavulanate: case report and characterization of the isolate","volume":"57","author":"Lagac\u00e9-Wiens","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pedneo.2021.01.005_bib29","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1128\/AAC.00068-06","article-title":"CTX-M-type extended-spectrum \u03b2-lactamases in Italy: molecular epidemiology of an emerging countrywide problem","volume":"50","author":"Mugnaioli","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pedneo.2021.01.005_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.14777\/uti.2017.12.2.77","article-title":"The antibiotic susceptibility of Escherichia coli from community-acquired uncomplicated urinary tract infection: a focused on fosfomycin","volume":"12","author":"Choe","year":"2017","journal-title":"Urogenit Tract Infect"},{"key":"10.1016\/j.pedneo.2021.01.005_bib31","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.1542\/peds.2011-1546","article-title":"Changing epidemiology of bacteremia in infants aged 1 week to 3 months","volume":"129","author":"Greenhow","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2021.01.005_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1590\/1678-4685-jbn-3602","article-title":"Clinical and laboratory features of urinary tract infections in young infants","volume":"40","author":"Lo","year":"2018","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.pedneo.2021.01.005_bib33","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/INF.0000000000000110","article-title":"Urinary tract infection in outpatient febrile infants younger than 30 days of age: a 10-year evaluation","volume":"33","author":"Bonadio","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.pedneo.2021.01.005_bib34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/CMR.3.1.46","article-title":"The life and times of the Enterococcus","volume":"3","author":"Murray","year":"1990","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.pedneo.2021.01.005_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2014.08.018","article-title":"Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae","volume":"29","author":"Asakura","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.pedneo.2021.01.005_bib36","first-page":"165","article-title":"Vital signs: carbapenem-resistant Enterobacteriaceae","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.pedneo.2021.01.005_bib37","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1128\/JCM.00433-06","article-title":"Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates","volume":"44","author":"Spanu","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.pedneo.2021.01.005_bib38","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/JCM.02130-10","article-title":"Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae","volume":"49","author":"Garrec","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.pedneo.2021.01.005_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijid.2016.11.010","article-title":"Community-onset extended-spectrum-\u03b2-lactamase-producing Escherichia coli sequence type 131 at two Korean community hospitals: the spread of multidrug-resistant E. coli to the community via healthcare facilities","volume":"54","author":"Kim","year":"2017","journal-title":"Int J Infect Dis"}],"container-title":["Pediatrics & Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957221000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957221000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:55:39Z","timestamp":1761749739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957221000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1875957221000073"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2021.01.005","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-carbapenem antimicrobial therapy in young infant with urinary tract infections caused by community-acquired extended-spectrum \u03b2-lactamase-producing Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2021.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}